Hosted by: Michael Greenberg, MD

Program Description:

This activity is jointly sponsored by the National Comprehensive Cancer Network (NCCN) and Prova Education.

As the second most common hematological malignancy, multiple myeloma has an estimated age-adjusted incidence of 7.5 per 100,000 men and 4.8 per 100,000 women in the U.S. In 2012, it was estimated that there were over 22,300 new cases and over 10,700 deaths attributed to multiple myeloma. Join us and our expert faculty in this challenging patient case as we explore standard-of-care diagnostic and treatment thought processes so critical to optimally managing patients with multiple myeloma.

Estimated time to complete activity: 15 minutes

Hosted by: Prova Education

Program Description:

Benign prostatic diseases result in significant morbidity and decreased quality of life. This CME lecture will help to identify the physiologic and psychologic impact on male sexual health, identify management options, and discuss similarities and differences in the epidemiology and pathophysiology to more effectively screen and diagnose these conditions.

Estimated time to complete activity: 30 minutes

Hosted by: Brian P. McDonough, MD, FAAFP

Program Description:

Early intervention of ulcerative colitis patients is critical to induce and maintain remission. This CME activity will use a case format to explore the differential workup of a newly diagnosed patient and ways to optimize 5-ASA agents.

Hosted by: Michael Greenberg, MD

Program Description:

Even though the significant research efforts for over the past 40 years have enabled profound changes in the approach and management of patients with advanced melanoma, the prognosis for patients remains poor. The NCI and ACS report that over 75,000 new cases of malignant melanoma were diagnosed in the US in 2011, and over 9,000 patients died from the disease. Melanoma has the fastest-rising incidence of any cancer, with an increase in the US from 1 in 1,500 in 1935 to a rate of 1 in 58 in 2011. Thus the importance of new information coming from a better understanding of Melanoma Heterogeneity and Drug Response.

Estimated time to complete activity: 30 minutes

Hosted by: John J. Russell, MD

Program Description:

Melanoma has been increasing in incidence for at least 30 years, but until recently there were no major advances in treatment. This CME activity will use a case to explore treatment resistance in patients with melanoma.

Hosted by: Matthew J. Sorrentino, MD, FACC, FASH

Program Description:

Benign prostatic diseases result in significant morbidity and decreased quality of life. This CME activity will help to identify the physiologic and psychologic impact on male sexual health, identify management options, and discuss similarities and differences in the epidemiology and pathophysiology to more effectively screen and diagnose these conditions.  

Estimated time to complete activity: 15 minutes

Hosted by: Matthew Birnholz, MD

Program Description:

WELCOME TO A PROJECT ONCOLOGY^® CME ACTIVITY

Even though the significant research efforts for over the past 40 years have enabled profound changes in the approach and management of patients with advanced melanoma, the prognosis for patients remains poor. The NCI and ACS report that over 75,000 new cases of malignant melanoma were diagnosed in the US in 2011, and over 9,000 patients died from the disease. Melanoma has the fastest-rising incidence of any cancer, with an increase in the US from 1 in 1,500 in 1935 to a rate of 1 in 58 in 2011. Thus the importance of new information coming from clinical trials.

Estimated time to complete activity: 30 minutes

Hosted by: Omnia Education

Program Description:

Nearly 1 in 6 Americans may be afflicted with OAB with only 16% of patients actually seeking medical treatment. Women experience urinary incontinence twice as often as men. And while OAB is a prevalent condition, many physicians do not screen for it if it is not a chief complaint of the patient. Most critical, the correct differential diagnosis of OAB is essential, greatly improving the likelihood of selecting appropriate therapeutic options for each individual woman.

Join us as Dr. Andrea Singer addresses how physicians can identify and overcome barriers that hinder increasing the screening rate of women for OAB, as well as explore the pharmacologic and non-pharmacologic treatment strategies for this condition.

Estimated time to complete this activity: 30 minutes

Hosted by: Brian P. McDonough, MD, FAAFP

Program Description:

WELCOME TO A PROJECT ONCOLOGY^® CME ACTIVITY

Melanoma has been increasing in incidence for at least 30 years, but until recently there were no major advances in treatment. This CME activity will use a case format to explore the relevance of genetics and genomics in relation to the longitudinal management of patients with melanoma.

Hosted by: Matthew Birnholz, MD

Program Description:

Every patient is not the same, and neither is every birth control. This activity will explore the interplay between hormonal contraceptives and medical conditions while applying principles of patient-centered care. It will also explore how to determine a patient's medical eligibility and effective counseling strategies for these various methods of birth control.

Estimated Time to Complete: 15 minutes

Hosted by: Prova Education

Program Description:

An estimated 5.4 million Americans of all ages had Alzheimer's Disease (AD) in 2012. This includes 5.2 million people age 65 and older and 200,000 individuals under age 65 who have younger-onset Alzheimer's. A paradigm shift in the diagnostic criteria for AD has occurred in the last year with new criteria and guidelines for managing AD having been updated, refined, and broadened compared with those published in 1984 by the Alzheimer's Association and the National Institute of Neurological Disorders and Stroke.

Join us as Drs. Lah, Hu and Levey discuss the new recommendations and guidelines for AD and emergent biomarkers/imaging as a critical adjunct to earlier identification and management of AD.

Estimated time to complete this activity: 1 hour

Hosted by: Robert Rubino, MD

Program Description:

Hysteroscopic surgery is being utilized more frequently, the result of improved surgical techniques and outcomes as well as increased patient demand for safe and effective less invasive procedures. This CME panel discussion will address approaches that enable physicians to perform hysteroscopic surgery more safely and effectively by focusing on best practices, overcoming operative difficulties, the inclusion of pharmacologic agents that improve visualization, reduce vascularity, and reduce the possibility of hyponatremia.

Hosted by: Matthew Birnholz, MD

Program Description:

Female sexual dysfunction is a common disorder that affects many women, but is hard for patients and physicians alike to discuss. This activity is designed to provide clinicians with strategies to effectively screen, diagnose and create a treatment plan for female sexual disorders (FSD). It will address the epidemiology of the six female sexual disorders and will aim to provide clinicians with the screening and assessment skills to overcome barriers surrounding diagnosis and management as well as improving clinician confidence and competence in communicating with patients about sexual problems.

Estimated Time to Complete:  15 minutes

Hosted by: Matthew Birnholz, MD

Program Description:

While cardiovascular disease mortality rates in men have steadily declined over the last 20 years, cardiovascular mortality for women remained flat or increased slightly during the 1980s and 1990s. Additionally for over 20 years mortality rates for women have exceeded those for men. This activity will present strategies for incorporating cardiovascular disease prevention, screening and management into the care of women, as well as discuss the various pharmacologic interventions for women at risk.

Estimated Time to Complete: 15 minutes

Hosted by: Lee Freedman, MD

Program Description:

As the public becomes increasingly aware of the availability of potent drugs for chronic pain relief, the number of patients seeking pain management is rising. Due to concern about addiction, fear of regulatory scrutiny, and lack of comfort level, many primary care clinicians are reluctant to prescribe opioids to patients who have chronic, non-cancer pain. There continues to be a need for alternative treatment options, specifically in patient populations with adherence challenges and those at particular risk for opioid abuse. In the past 20 years, a great deal of progress has been made in the treatment of severe chronic pain, including the use of analgesics via intrathecal delivery. In particular, non-opioid medications, delivered intrathecally may provide a compelling option for patients who either didn't respond well to their previous treatments or who are at-risk for opioid addiction/abuse.

Estimated time to complete activity: 30 Minutes

Hosted by: Brian P. McDonough, MD, FAAFP

Program Description:

Based on the substantial morbidity and mortality, the importance of stroke prevention in Atrial Fibrillation, or AF, cannot be overestimated. Guidelines recommend that patients with AF receive some form of antithrombotic therapy typically coupled with intervention(s) that further reduce their risk of stroke through management of heart rate or rhythm. Stroke risk, however, is not homogenous and varies widely, complicating both the assessment of stroke risk and individualizing strategies for stroke prevention. An effective, but safety-driven approach to treatment, is essential.

Join us as Drs. Abbott and Halperin discuss barriers in managing patients with AF, including 1) individualizing safe and effective oral anticoagulant (OAC) therapy; 2) developing longitudinal OAC treatment plans; and 3) addressing rate and rhythm control in appropriate patients.

Estimated time to complete activity: 30 minutes

Hosted by: Brian P. McDonough, MD, FAAFP

Program Description:

This multidisciplinary CME activity focuses on the co-management of patients coinfected with Hepatitis C Virus (HCV) and the Human Immunodeficiency Virus (HIV). In the United States, 15-30% of infected HCV patients are coinfected with HIV. These patients are complex to manage as they are not always easily identified; the urgency to treat them is even greater than those patients with a single infection. This panel discussion will address professional practice gaps for Primary Care Physicians, Gastroenterologists, Hepatologists and Infectious Disease Specialists, all of whom may have diagnostic and/or management responsibilities for HCV and HIV coinfected patients along the disease continuum and patient journey.

Estimated time to complete activity: 30 minutes

Hosted by: Matthew Birnholz, MD

Program Description:

This ReachMD CME activity is the last in a 3-part series of expert interviews focusing on Rh incompatibility between mother and infant. This interview will explore the available treatment options from a patient centered care perspective. The various treatment options will be discussed with respect to a patient's health status and potential patient/health system benefits of various treatment options.

Estimated time to complete activity: 15 minutes

After you have complete this activity, click here to participate in Parts 1 and 2 of this series:

• Part 1 with Andra H. James, MD, MPH
• Part 2 with Lee Philip Shulman, MD, FACOG, FACMG
  
  

Hosted by: Lee Freedman, MD

Program Description:

This ReachMD CME activity is the third in a 3-part series of expert interviews focusing on pediatric and adolescent vaccination. Pediatric and adolescent vaccinations have had a major impact on improving life expectancy and quality of life. The consequences and burden of disease has a significant impact on the population. Join us as Dr. Stephen Pelton addresses wide-ranging issues, including the repercussions associated with a failure to vaccinate or fully completing a vaccination series for the recommended pediatric/adolescent vaccines.

Estimated time to complete this activity: 15 minutes

After you have complete this activity, click here to participate in Parts 1 and 2 of this series:

• Part 1 with Dr. Edward J. Mayeaux
• Part 2 with Dr. Thomas C. Wright, Jr.

Hosted by: Matthew J. Sorrentino, MD, FACC, FASH

Program Description:

Atrial fibrillation, or AF, is the most common sustained atrial arrhythmia, affecting more than 2.2 million Americans. AF can be medically serious, greatly impacting a person’s quality of life, and putting them at increased risk for morbidity and mortality.

Join us as our panelists address implementing antiarrhythmic strategies over the short- and long-term, including evidence-based medical interventions and surgical ablation, all within the confines of a well-rounded management approach including anticoagulant therapy.

Estimated time to complete this activity: 15 minutes

Hosted by: Matthew Birnholz, MD

Program Description:

This ReachMD CME activity is the second in a 3-part series of expert interviews focusing on the obstetrical issue Rh incompatibility. Management of Rh incompatibility involves multiple providers, including Obstetricians and Gynecologists, Nurses, Labor & Deliver Nurses, Nurse Practitioners, Pharmacists and Blood-bank Personnel. This activity explores a patient's journey from diagnosis through treatment; as well as highlights what providers should look for in a patient's history to identify high-risk patients. Thus, the discussion encompasses a range of patients and how treatment decisions may change depending on each patient's presentation.

Estimated time to complete: 15 minutes

After you have complete this activity, click here to participate in Parts 1 and 3 of this series:

• Part 1 with Andra H. James, MD, MPH
• Part 3 with Jordan H. Perlow, MD
  
  

Hosted by: Matthew Birnholz, MD

Program Description:

Preserving fertility is a significant concern for women undergoing treatment for cancer, and for many the psychological and quality of life impact of cancer-related infertility is a great burden. Obstetrician/Gynecologists can play an important role in informing women of options that may help preserve the possibility of building a family. They, together with their colleagues in reproductive medicine and in oncology, can collaboratively educate patients facing treatment for cancer about options for fertility preservation.

Join us as our panel discusses a woman's fertility preservation options when facing a diagnosis of cancer and subsequent treatment.

Estimated time to complete: 15 minutes

Hosted by: Brian P. McDonough, MD, FAAFP

Program Description:

This ReachMD CME activity is the first in a 3-part series of expert interviews focusing on the important obstetrical issue of Rh incompatibility. This activity discusses the proper screening for, and management of, Rh incompatibility, which was identified by the Department of Health and Human Services U.S. Preventive Services Task Force as an important component of obstetrical care. Additionally, the American College of Obstetricians and Gynecologists (ACOG) has developed a series of Practice Bulletins focused on the prevention of Rh incompatibility.

Estimated time to complete: 15 minutes

After you have complete this activity, click here to participate in Parts 2 and 3 of this series:

• Part 2 with Lee Philip Shulman, MD, FACOG, FACMG
• Part 3 with Jordan H. Perlow, MD
  
  

Hosted by: Matthew Birnholz, MD

Program Description:

This ReachMD CME activity is the second in a 3-part series of expert interviews focusing on pediatric and adolescent vaccination. Pediatric and adolescent vaccinations have had a major impact on improving life expectancy and quality of life. However, vaccination uptake and hence the protection afforded remain suboptimal. Join us as Thomas C. Wright, Jr., MD, addresses wide-ranging issues including overcoming barriers to improving pediatric and adolescent vaccination rates; and approaches to help ensure compliance with current ACIP recommendations for pediatric and adolescent patients, including catch-up and HPV vaccination.

Estimated time to complete: 15 minutes

After you have complete this activity, click here to participate in Parts 2 and 3 of this series:

• Part 1 with Dr. Edward J. Mayeaux, Jr.
• Part 3 with Dr. Stephen I. Pelton
  
  

Hosted by: Curatio CME Institute

Program Description:

Effective management of psoriasis and psoriatic arthritis must take individual patient characteristics, comorbid diseases, access to treatment, and disease severity-as well as patient preferences-into consideration. This Biologic Bulletin reviews safety issues and efficacy data for traditional systemic therapies and biologic agents based on guidelines from the American Academy of Dermatology.

Estimated time to complete activity: 1 hour

ReachMD Participants: Click here to visit our partner and participate in this activity.

Hosted by: Matthew Birnholz, MD

Program Description:

Low trauma fragility fractures associated with osteoporosis occur in up to 50% of women and 30% of men during their lifetime. When they occur, especially in the aged, the risk for potentially debilitating morbidity, if not fracture-associated death, is greatly increased.

Join us as our panel discusses fracture management, including prevention strategies that strive to optimize outcomes for patients at risk for/following low trauma fracture. Our faculty also addresses mechanisms to improve the interdisciplinary collaboration and communication so necessary when providing a high standard-of-care to our patients with osteoporosis.

Estimated Time to Complete: 30 minutes

Hosted by: Matthew J. Sorrentino, MD, FACC, FASH

Program Description:

Excessive menstrual bleeding, menorrhagia, is a debilitating health condition for many women, affecting approximately 10 million women in the U.S. each year. Menorrhagia is a medical discussion women typically do not have with their health care provider. Unaddressed menorrhagia can wreak havoc on the personal and professional lives of women affected.

Join us as we discuss menorrhagia, providing not only information on the latest approaches to managing menorrhagia, but more so, guidance for integrating menstruation issues into the personal conversations you have with your patients.

Hosted by: Omnia Education

Program Description:

Screening for fetal chromosomal conditions has been identified as an important component of obstetrical care by the American College of Obstetricians and Gynecologists. New data on emerging technologies show improvements in low-risk, non-invasive screening methods. This series of online and satellite radio CME activities discusses appropriate screening and diagnostic protocols based on the evidence-base, and explores the latest technologies as a means to improve clinical decision-making related to screening for fetal abnormalities. 

Click here to check out: Recent Changes in Prenatal Genetic Evaluation, presented by Ronald Wapner, MD

Hosted by: Matthew Birnholz, MD

Program Description:

This ReachMD CME activity is the first in a 3-part series of expert interviews focusing on pediatric and adolescent vaccination. Pediatric and adolescent vaccinations have had a major impact on improving life expectancy and quality of life. However, vaccination uptake and therefore the protection afforded remain suboptimal. Join us as Edward Mayeaux, MD, focuses on wide-ranging issues including overcoming barriers to improving pediatric and adolescent vaccination rates; and approaches to help ensure compliance with current ACIP recommendations for pediatric and adolescent patients, including catch-up and HPV vaccination.

Estimated time to complete: 15 minutes

After you have complete this activity, click here to participate in Parts 2 and 3 of this series:

• Part 2 with Dr. Thomas C. Wright, Jr.
• Part 3 with Dr. Stephen I. Pelton

Hosted by: Omnia Education

Program Description:

Ten million Americans have osteoporosis and 34 million are osteopenic, with over 2 million osteoporotic fractures per year. One of every two women age ≥50 will have a fracture before her death. Fractures lead to substantial disability and increased mortality, not to mention high financial costs to the health care system.

Join us as we address performance gaps in the diagnosis and treatment of osteoporosis; how to best apply clinical tools and practice guidelines to prevent osteoporotic fracture; appropriately treat fracture patients to prevent additional fracture; and ensure patient compliance and persistence with their individualized treatment regimen.

Estimated time to complete activity: 30 minutes

Hosted by: Prova Education

Program Description:

Primary care is responsible for managing patients with hyperlipidemia or mixed dyslipidemia. Many of these patients present with concomitant medical problems, including diabetes, hypertension, and coronary artery disease. Statins have been consistently shown to be highly effective in treating dyslipidemias, and as a class are generally well tolerated. However, clinical concerns relating to statin therapy include myotoxicity and hepatotoxicity, and more recently, association with an increased risk for developing new-onset T2DM.

A variety of factors contribute to this risk beyond age and gender. Most clinical issues are typically caused by innate statin metabolism associated with polypharmacy and/or a patient's genetic polymorphism, and their impact on statin efficacy, and safety. These issues take on added relevance with the continuing suggestion for more universal application of statins in primary prevention efforts.

Join us for this online CME activity as we take an in-depth look at real-life statin efficacy and safety, including critical perspectives on polypharmacy and pharmacogenetics.

ReachMD Smart Phone App users: Please note that there is an optional video presentation for this activity. Please visit www.reachmd.com

Hosted by: No ReachMD Host

Program Description:

Chronic musculoskeletal pain is often under-recognized and under-treated in the primary care setting. At least 40% of patients treated for chronic pain fail to achieve adequate relief. This program discusses the management of patients with chronic pain from the perspectives of both primary care and the pain specialist, with the objective of improving overall patient outcomes.

ReachMD Smart phone users: An optional video presentation is available at www.reachmd.com. 

Hosted by: Brian P. McDonough, MD, FAAFP

Program Description:

The importance of maintaining glycemic control in managing type 2 diabetes is well documented, repeatedly urged by health care professionals, but rarely achieved by patients. There are many barriers in diabetes management for both physician and patient. The focus of good glycemic control often rests with adherence to a healthy lifestyle with nutritional balance; and both adherence and persistence with prescribed medication.

Hosted by: Matthew Birnholz, MD

Program Description:

This segment is part one of a two-part series entitled Fetal Chromosomal Abnormalities. 

Hosted by: Matthew Birnholz, MD

Program Description:

This segment is part two of a two-part series entitled Fetal Chromosomal Abnormalities.